Monday, December 23, 2024
- Advertisement -spot_img

TAG

Trastuzumab

Biocon Q3 FY17 Net Profit Up 65% at Rs 171 Crore

Bengaluru, India, January 24, 2017/Team Estrade//-- Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced today its consolidated financial results for the...

Latest news

- Advertisement -spot_img